11 results
10-Q
2021 Q3
EX-2.1
NMTRQ
9 Meters Biopharma, Inc.
Quarterly report
15 Nov 21
7:39am
8-K
EX-2.1
NMTRQ
9 Meters Biopharma, Inc.
4 May 20
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC
5:24pm
8-K
EX-2.1
NMTRQ
9 Meters Biopharma, Inc.
17 Dec 19
Entry into a Material Definitive Agreement
4:03pm
8-K
EX-2.1
NMTRQ
9 Meters Biopharma, Inc.
7 Oct 19
Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases
6:59am
8-K
EX-2.1
NMTRQ
9 Meters Biopharma, Inc.
5 Jan 18
Monster Digital and Innovate Biopharmaceuticals Extend Outside Closing Date for Merger
12:00am
DEFA14A
EX-2.1
ah67bxla6t
6 Jul 17
Additional proxy soliciting materials
12:00am
8-K
EX-2.2
btjiew1wdqi4ci0q
6 Jul 17
Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement
12:00am
DEFA14A
EX-2.2
bwxd086r6lq
6 Jul 17
Additional proxy soliciting materials
12:00am
8-K
EX-2.3
5ds2t
6 Jul 17
Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement
12:00am
8-K
EX-2.1
zxh w5hjjef42xli
6 Jul 17
Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement
12:00am
DEFA14A
EX-2.3
ka7fadykgc r6
6 Jul 17
Additional proxy soliciting materials
12:00am
- Prev
- 1
- Next